On Friday, March 4, 2016, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) made recommendations on the selection of strains to be included in the influenza virus vaccine for the 2016 to 2017 influenza season in the U.S. Members agreed unanimously with the World Health Organization (WHO) strain recommendations.
Back to All Events
Earlier Event: March 1
Science Board to the FDA
Later Event: March 8
Pharmacy Compounding Advisory Committee